Related Experiment Videos
Risk-based management of solid tumors in children
1Department of Surgery, Section of Pediatric Surgery, Indiana University School of Medicine and the J. W. Riley Hospital for Children, Indianapolis, Indiana 46202, USA.
American Journal of Surgery
|January 4, 2001
Summary
Identifying genetic factors in childhood cancers allows for risk-based treatment. This personalized approach improves survival rates and quality of life for pediatric patients with malignant solid tumors.
Area of Science:
- Pediatric Oncology
- Cancer Genetics
- Tumor Biology
Background:
- Significant improvements in pediatric malignant solid tumor survival (56% to 75%) over 25 years.
- Multidisciplinary cooperative studies and combined therapies (surgery, chemotherapy, irradiation) have been crucial.
- Recognition of biologic and genetic factors enables risk categorization and individualized treatment.
Purpose of the Study:
- To describe genetic alterations and biologic factors in pediatric endocrine neoplasia syndromes, Wilms' tumor, and neuroblastoma.
- To explain how these factors inform risk categorization for treatment planning.
- To highlight the development of individualized care protocols based on risk stratification.
Main Methods:
- Analysis of genetic alterations and biologic factors in specific pediatric tumors.
- Categorization of tumors into low-, intermediate-, and high-risk groups.
- Design of new treatment protocols based on patient risk stratification.
Main Results:
- New treatment protocols are designed based on tumor risk categorization (low, intermediate, high).
- Treatment intensity and type are determined by the patient's risk category.
- This approach allows for tailored therapeutic strategies.
Conclusions:
- Biologic markers and gene alterations are critical for determining tumor behavior (low vs. high-risk).
- Risk-based management enables individualized care, maximizing survival.
- This strategy minimizes morbidity and improves the quality of life for pediatric cancer patients.